-
1
-
-
0027516695
-
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
-
Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
-
(1993)
Cancer
, vol.71
, pp. 2585-2597
-
-
Fine, H.A.1
Dear, K.B.2
Loeffler, J.S.3
Black, P.M.4
Canellos, G.P.5
-
2
-
-
0037161024
-
Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials
-
Stewart LA: Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002
-
(2002)
Lancet
, vol.359
, pp. 1011-1018
-
-
Stewart, L.A.1
-
3
-
-
0027972896
-
Chemotherapy for anaplastic oligodendroglioma
-
National Cancer Institute of Canada Clinical Trials Group
-
Cairncross G, MacDonald D, Ludwin S, et al.: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J. Clinical Oncology 12: 2013-2012, 1994
-
(1994)
J. Clinical Oncology
, vol.12
, pp. 2013-12012
-
-
Cairncross, G.1
MacDonald, D.2
Ludwin, S.3
-
5
-
-
0032855728
-
Multicenter phase II trial of Temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
-
Yung WKA, Prados MD, Yaya-Tur R, et al.: Multicenter phase II trial of Temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clinical Oncology 17(9): 2762-2771, 1999
-
(1999)
J Clinical Oncology
, vol.17
, Issue.9
, pp. 2762-2771
-
-
Yung, W.K.A.1
Prados, M.D.2
Yaya-Tur, R.3
-
6
-
-
0034034511
-
Health-related quality of life in patients treated with Temozolomide versus Procarbazine for recurrent glioblastoma multiforme
-
Osoba D, Brada M, Yung WKA, et al.: Health-related quality of life in patients treated with Temozolomide versus Procarbazine for recurrent glioblastoma multiforme. J Clinical Oncology 18(7): 1481-1491, 2000
-
(2000)
J Clinical Oncology
, vol.18
, Issue.7
, pp. 1481-1491
-
-
Osoba, D.1
Brada, M.2
Wka, Y.3
-
7
-
-
0017598095
-
Mechanism of uptake of nitrosourea by L5178Y lymphoblasts in vitro
-
Begleiter A, Lam H-YP, Goldenberg GJ: Mechanism of uptake of nitrosourea by L5178Y lymphoblasts in vitro. Cancer Res 37: 1022-1027, 1977
-
(1977)
Cancer Res
, vol.37
, pp. 1022-1027
-
-
Begleiter, A.1
Lam, H.-Y.P.2
Goldenberg, G.J.3
-
8
-
-
0027323988
-
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell line SK-MG-1 is mediated by an epinephrine sensitive carrier system
-
Noë AJ, Malapetsa A, Panasci LC: Transport of (2-chloroethyl)-3- sarcosinamide-1-nitrosourea in human glioma cell line SK-MG-1 is mediated by an epinephrine sensitive carrier system. Mol Pharmacol 44: 204-209, 1993
-
(1993)
Mol Pharmacol
, vol.44
, pp. 204-209
-
-
Noë, A.J.1
Malapetsa, A.2
Panasci, L.C.3
-
9
-
-
0030832163
-
(2-chloroethyl)-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts
-
Marcantonio D, Panasci LC, Hollingshead MG, Alley MC, Camalier RF, Sausville EA, Dykes DJ, Carter CA, Malspeis L: (2-chloroethyl)-3-sarcosinamide- 1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Cancer Res 57: 3895-3898, 1997
-
(1997)
Cancer Res
, vol.57
, pp. 3895-3898
-
-
Marcantonio, D.1
Panasci, L.C.2
Hollingshead, M.G.3
Alley, M.C.4
Camalier, R.F.5
Sausville, E.A.6
Dykes, D.J.7
Carter, C.A.8
Malspeis, L.9
-
12
-
-
0037440120
-
SarCNU, a Nitrosourea Analog on a Day 1, 5, and 9 Oral Schedule: A Phase I and pharmacokinetic study in patients with advanced solid tumors
-
Panasci L, Stinson SF, Melnychuk D, Sandor V, Miller WH Jr, Batist G, Patenaude F, Bangash N, Panarello L, Alaoui-Jamali M, Sausville E: SarCNU, a Nitrosourea Analog on a Day 1, 5, and 9 Oral Schedule: A Phase I and pharmacokinetic study in patients with advanced solid tumors. J Clin Oncol 21: 232-240, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 232-240
-
-
Panasci, L.1
Stinson, S.F.2
Melnychuk, D.3
Sandor, V.4
Miller Jr., W.H.5
Batist, G.6
Patenaude, F.7
Bangash, N.8
Panarello, L.9
Alaoui-Jamali, M.10
Sausville, E.11
-
13
-
-
0017711399
-
Criteria for evaluating patients undergoing chemotherapy for malignant brain tumours
-
Levin, VA, Crafts, DC, Norman, DM, Hoffer, PB, Spire, JP, Wilson, CB: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumours. J Neurosurg 47: 329-335, 1977
-
(1977)
J Neurosurg
, vol.47
, pp. 329-335
-
-
Levin, V.A.1
Crafts, D.C.2
Norman, D.M.3
Hoffer, P.B.4
Spire, J.P.5
Wilson, C.B.6
-
14
-
-
0020108590
-
One sample multiple testing procedure for phase II clinical trials
-
Fleming TR: One sample multiple testing procedure for phase II clinical trials. Biometrics 38: 143-151, 1982
-
(1982)
Biometrics
, vol.38
, pp. 143-151
-
-
Fleming, T.R.1
-
16
-
-
0024512604
-
The pulmonary toxicity of nitrosoureas
-
Smith AC: The pulmonary toxicity of nitrosoureas. Parmac Ther 41: 443-160, 1989
-
(1989)
Parmac Ther
, vol.41
, pp. 443-1160
-
-
Smith, A.C.1
|